Effects of menatetrenone on the decrease in calcium balance induced by vitamin K-deficient diet and sodium loading in rats. 1994

T Tomiuga, and M Kobayashi, and Y Nakajima, and M Bessho, and Y Katoh, and K Hara, and Y Akiyama, and T Nakamura, and T Tajima
Department of Drug Research II, Eisai Co., Ltd, Tokyo, Japan.

The effects of menatetrenone (2-methyl-3-tetraprenyl-1,4-naphthoquinone, MK-4) on calcium balance were studied in male Sprague-Dawley rats. Experiment 1: Rats in metabolic cages that were fed a vitamin K-deficient diet and injected daily with latamoxef (100 mg/kg, i.p.) were either treated or untreated with MK-4 for 7 days. Daily food intake, urine volume and feces weight were determined, and calcium concentration in these samples was measured. Calcium balance was calculated as the difference between calcium intake and urinary and fecal calcium excretion. Cumulative calcium balance in the vitamin K-deficient group treated with latamoxef was lower than that in normal rats; this balance was significantly improved by MK-4 (1 and 10 mg/kg, s.c.) administered for 7 days. Experiment 2: Rats were fed a vitamin K-deficient diet containing 4.6% sodium chloride for 6 weeks. MK-4 was administered as a dietary supplement. Forty-eight-hour calcium balance, determined once a week, was significantly reduced compared with that of normal rats after 3 and 5 weeks; the balance was restored dose-dependently by MK-4 administration (1 and 10 mg/kg). Experiment 3: Rats were subjected to the same experimental conditions as experiment 2 for 6 weeks, and intestinal calcium transport was determined using an everted gut-sac technique. Calcium transport was reduced by the high sodium, vitamin K-deficient diet, and this reduction was restored by MK-4 administration (10 mg/kg). These results suggest that MK-4 improves the reduced calcium balance by increasing intestinal calcium absorption in these rats.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D007422 Intestines The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE. Intestine
D007677 Kidney Function Tests Laboratory tests used to evaluate how well the kidneys are working through examination of blood and urine. Function Test, Kidney,Function Tests, Kidney,Kidney Function Test,Test, Kidney Function,Tests, Kidney Function
D008297 Male Males
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D006490 Hemostatics Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. Antihemorrhagic,Hemostatic,Antihemorrhagics

Related Publications

T Tomiuga, and M Kobayashi, and Y Nakajima, and M Bessho, and Y Katoh, and K Hara, and Y Akiyama, and T Nakamura, and T Tajima
January 2002, Japanese journal of pharmacology,
T Tomiuga, and M Kobayashi, and Y Nakajima, and M Bessho, and Y Katoh, and K Hara, and Y Akiyama, and T Nakamura, and T Tajima
February 1986, Endocrinologia japonica,
T Tomiuga, and M Kobayashi, and Y Nakajima, and M Bessho, and Y Katoh, and K Hara, and Y Akiyama, and T Nakamura, and T Tajima
August 2005, Journal of nutritional science and vitaminology,
T Tomiuga, and M Kobayashi, and Y Nakajima, and M Bessho, and Y Katoh, and K Hara, and Y Akiyama, and T Nakamura, and T Tajima
October 2003, Bone,
T Tomiuga, and M Kobayashi, and Y Nakajima, and M Bessho, and Y Katoh, and K Hara, and Y Akiyama, and T Nakamura, and T Tajima
June 1993, Japanese journal of pharmacology,
T Tomiuga, and M Kobayashi, and Y Nakajima, and M Bessho, and Y Katoh, and K Hara, and Y Akiyama, and T Nakamura, and T Tajima
January 2005, Hormone research,
T Tomiuga, and M Kobayashi, and Y Nakajima, and M Bessho, and Y Katoh, and K Hara, and Y Akiyama, and T Nakamura, and T Tajima
January 2004, Hormone research,
T Tomiuga, and M Kobayashi, and Y Nakajima, and M Bessho, and Y Katoh, and K Hara, and Y Akiyama, and T Nakamura, and T Tajima
September 1998, Bone,
T Tomiuga, and M Kobayashi, and Y Nakajima, and M Bessho, and Y Katoh, and K Hara, and Y Akiyama, and T Nakamura, and T Tajima
December 1962, The Journal of nutrition,
T Tomiuga, and M Kobayashi, and Y Nakajima, and M Bessho, and Y Katoh, and K Hara, and Y Akiyama, and T Nakamura, and T Tajima
December 1958, Comptes rendus hebdomadaires des seances de l'Academie des sciences,
Copied contents to your clipboard!